A Hypothesis From Metabolomics Analysis of Diabetic Retinopathy: Arginine-Creatine Metabolic Pathway May Be a New Treatment Strategy for Diabetic Retinopathy
Diabetic retinopathy is one of the serious complications of diabetes, which the leading causes of blindness worldwide, and its irreversibility renders the existing treatment methods unsatisfactory. Early detection and timely intervention can effectively reduce the damage caused by diabetic retinopat...
Main Authors: | Ye Sun, Ling Kong, Ai-Hua Zhang, Ying Han, Hui Sun, Guang-Li Yan, Xi-Jun Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-03-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2022.858012/full |
Similar Items
-
Integrated Analysis of Metabolomics and Lipidomics in Plasma of T2DM Patients with Diabetic Retinopathy
by: Chun Ding, et al.
Published: (2022-12-01) -
Metabolomics of various samples advancing biomarker discovery and pathogenesis elucidation for diabetic retinopathy
by: Xiaohui Du, et al.
Published: (2022-10-01) -
Recent Advances and Perspectives in Relation to the Metabolomics-Based Study of Diabetic Retinopathy
by: Shuling He, et al.
Published: (2023-09-01) -
Plasma metabolomic profiling of proliferative diabetic retinopathy
by: Xiao-Rong Zhu, et al.
Published: (2019-05-01) -
Metabolic correction of experimental diabetic retinopathy
by: I.V. Savitskyi, et al.
Published: (2017-12-01)